Joel Topf spoke with Bradley Marder of Amgen about gout studies at the NKF Spring Clinical Meetings 2025. Joel Topf spoke to Excellence in Transplantation Award winner Jayme Locke at the National Kidney Foundation SCM25. Tonix Pharmaceuticals and Makana Therapeutics will collaborate on preclinical xenotransplantation research and development. Dr. Thomas Pham spoke to us about kidney donation during National Donate Life Month. The National Kidney Foundation (NKF) announced the Spring Clinical Meetings 2025 (SCM25) Outstanding Poster honorees. Researchers in China announced that they have performed a successful transplant of a gene-edited pig kidney into a patient. A study examined bone health among a subset of kidney transplant patients from the PROTECT trial of pegloticase for gout. Researchers examined the association between gout and odds of being wait-listed for a kidney transplant among patients on HD. The Freely Filtered Filtrate discusses the top nephrology stories of 2024, including FLOW, cyberattacks, and IgAN trials. A global review noted changes in kidney care delivery but revealed gaps in access to kidney replacement therapies. Researchers studied outcomes of transplant recipients who received kidneys from toxoplasma-positive versus negative donors. A study examined prognosis and lifespan of adults who received kidney replacement therapy as children. In March, a patient at the Cleveland Clinic became the first in the US to receive a robot-assisted dual kidney transplant. The co-directors of Stanford's NephroNICU Program spoke about their unique program. Suzanne Watnick shared thoughts on the Shaul G. Massry lectureship, COVID-19, kidney transplantation, and policy issues. Michael Spigler of American Kidney Fund discussed its work and its findings on education level and transplant discussions. Speakers at the American Transplant Congress will include transplantation’s leading luminaries and thinkers. Dr. Robert Montgomery spoke about advances in xenotransplantation, including the pig kidney transplant he recently performed. Public benefit corporation 34 Lives made its first successful rescue of a human kidney regarded as unusable. A study examined gastrointestinal bleeding in patients with chronic kidney disease (CKD).